Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.

Tumour virus research - 1 Jun 2026

Yu Dongbo, Wang Jiao, Li Ying, Wang Hui, Zhang Jieqiong, Wang Mingming, Li Haotian, Zhang Li, Zhu Na, Lu Xuexin, Wang Shiwen

Abstract excerpt

Human papillomavirus type 16 (HPV16) causes over 50% of HPV-related cervical cancers. With the widespread use of virus-like particle (VLP)-based HPV prophylactic vaccines, investigating the differences in viral assembly, infectivity and antigenic properties among different variants is highly important for further eliminating diseases caused by HPV. We analyzed HPV16 L1 protein sequences from the NCBI database and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Capsid Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Human papillomavirus 16

Share to Molecular Dynamics Simulation

Share to Oncogene Proteins, Viral

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 41941926
DOI: 10.1016/j.tvr.2026.200341
PMCID: PMC13091289

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptibility of naturally human papillomavirus type 16 major capsid protein L1 variants to vaccines and predictions of future evolutionary trends.PMID 41941926Read ↗

HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.Semantic proximity Read ↗

Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.Semantic proximity Read ↗

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.Semantic proximity Read ↗

Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.Semantic proximity Read ↗

Characterization of major capsid protein (L1) variants of Human papillomavirus type 16 by cervical neoplastic status in Indian women: Phylogenetic and functional analysis.Semantic proximity Read ↗

Genetic variability in the major capsid L1 protein of human papillomavirus type 16 (HPV-16) and 18 (HPV-18).Semantic proximity Read ↗

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency.Semantic proximity Read ↗

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.Semantic proximity Read ↗

Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1Semantic proximity Read ↗

Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coliSemantic proximity Read ↗

Mutation Profiles, Glycosylation Site Distribution and Codon Usage Bias of Human Papillomavirus Type 16.Semantic proximity Read ↗

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.